Search Results 341-350 of 16261 for anti-TNF drugs

1. Labor and delivery: Pain medications - Mayo Clinic

   Many types of medications can ease pain during labor and delivery. Ideally, the drugs used are safe for mother and baby, don't interfere with labor and ...

2. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

   A phase 1 study finds low incidence of severe side effects and high response rate for ide-cel, an anti-BCMA CAR-T cell therapy for relapsed or refractory ...

3. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

   Use of anti-inflammatory medications listed below within the last 30 days: Leflunomide; Sulfasalazine; Mycophenolate; Cyclosporine; Cyclophosphamide ...

4. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... For any other TNF-α antagonist, the participant ... Has had previous exposure to approved or investigational ...

5. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

   A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.

6. Targeting VEGF-Independent Proangiogenic Pathways in Anti-VEGF Refractory Renal Cell Cancer - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

   Mukhopadhyay's lab is developing novel treatment strategies to target these pathways for refractory and highly aggressive tumor types and for sarcomatoid renal ...

7. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

   By condition, treatment or drug name ... [TNF-α] monoclonal antibody), immunosuppressants ... Subjects taking any nonsteroidal anti-inflammatory drugs that cannot be ...

8. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

   Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

9. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   ... Anti-TNF therapy within 12 weeks prior to Screening (Visit 1); Anti-CD52 (alemtuzumab) within 6 months prior to Screening (Visit 1). Liver Function Tests ...

10. A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... treatment with an anti LAG-3 or anti TIM-3 is also excluded; Known ...